Zenotech Laboratories Limited (532039) Fair Value & Analysis
Other · IN · Market cap ₹2.1B
Fair value as of: Aug 13, 2026
From 13 valuation models · updated 5 days ago
A solid business, but screening 84% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (₹8.07). The favourable scenario is already priced in.
- Solid but not exceptional quality (53/100) and above fair value, neither a clear bargain nor a standout compounder.
- The models converge in a tight band (₹7.44 to ₹8.07), unusually little disagreement for a valuation.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range ₹34.29 – ₹101.67 · fair‑value band ₹7.44 – ₹8.07 · the ₹47.62 price screens above the ₹7.78 fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
Zenotech Laboratories Limited (532039) currently trades at ₹47.62, while our model-based Fair Value estimate is ₹7.78, implying the stock looks roughly 83.7% overvalued today. The Quality Score stands at 53/100 (solid quality), in the Other sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Over the trailing twelve months, Zenotech Laboratories Limited generated revenue of ₹197M at a net margin of 22.1%. Revenue declined 58.8% year over year. It earns a return on equity of 9.7%. Net debt stands at ₹35.9M. Fundamentals as of Aug 13, 2026
Our scenario range runs from ₹7.44 (bear case) to ₹8.07 (bull case); at ₹47.62, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 27% below its 52-week high and 42% above its 52-week low, currently above its 200-day average. For context, the median of 10 Other peers we cover trades at -24% fair-value upside, at -84%, 532039 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 13 models by family
Widest divergence: DCF Models (₹12.52) versus Earnings-Based (₹8.18). Highest evidence: Growth DCF (80).
Notify me when 532039 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 55 · Market factors (momentum, volatility) 41
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Zenotech Laboratories Limited operates as a pharmaceutical specialty generic injectables company in India. The company manufactures oncology, biotechnology, and general injectable products, such as granulocyte-colony stimulating factor (GCSF) and granulocyte-macrophage colony-stimulating factor (GMCSF).
Full company description
Zenotech Laboratories Limited operates as a pharmaceutical specialty generic injectables company in India. The company manufactures oncology, biotechnology, and general injectable products, such as granulocyte-colony stimulating factor (GCSF) and granulocyte-macrophage colony-stimulating factor (GMCSF). Its injectable product portfolio primarily serves therapy areas, such as oncology and anesthesiology. The company was formerly known as Sunline Technologies Limited and changed its name to Zenotech Laboratories Limited in August 2004. Zenotech Laboratories Limited was incorporated in 1989 and is based in Hyderabad, India.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Zenotech Laboratories Limited reported revenue of ₹396M in FY2026 versus ₹366M in FY2022, a compound +2.0%/yr. Reported net income was −₹10.7M in FY2026.
532039 screens 84% overvalued. Compare with Federal Home Loan Mortgage Corporation →
Peer Group
Other · 373 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Other median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Other stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Federal Home Loan Mortgage Corporation FREJO | $15.58 | $51.90 | +233% |
| 533278 533278 | ₹409.15 | ₹660.78 | +62% |
| Nestl?? India Limited 500790 | ₹1,497 | ₹191.93 | -87% |
| ITC Limited 500875 | ₹279.50 | ₹212.74 | -24% |
| Wipro Limited 507685 | ₹183.80 | ₹193.38 | +5% |
| 540376 540376 | ₹4,054 | ₹1,542 | -62% |
| 540777 540777 | ₹537.50 | ₹149.72 | -72% |
| Lupin Limited 500257 | ₹2,265 | ₹1,983 | -12% |
| Dabur India Limited 500096 | ₹413.80 | ₹122.93 | -70% |
| 540719 540719 | ₹1,835 | ₹872.41 | -52% |
Compare Zenotech Laboratories Limited with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
Frequently asked questions
Is Zenotech Laboratories Limited (532039) overvalued or undervalued?
What is the fair value of 532039?
What is the quality score of 532039?
What is the revenue of Zenotech Laboratories Limited (532039)?
What is the net profit margin of 532039?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Zenotech Laboratories Limited and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.